Logo image of JEN.DE

JENOPTIK AG (JEN.DE) Stock Fundamental Analysis

FRA:JEN - Deutsche Boerse Ag - DE000A2NB601 - Common Stock - Currency: EUR

19.17  +0.03 (+0.16%)

Fundamental Rating

5

Overall JEN gets a fundamental rating of 5 out of 10. We evaluated JEN against 54 industry peers in the Electronic Equipment, Instruments & Components industry. While JEN has a great profitability rating, there are some minor concerns on its financial health. JEN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year JEN was profitable.
JEN had a positive operating cash flow in the past year.
Each year in the past 5 years JEN has been profitable.
JEN had a positive operating cash flow in each of the past 5 years.
JEN.DE Yearly Net Income VS EBIT VS OCF VS FCFJEN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

JEN's Return On Assets of 5.14% is amongst the best of the industry. JEN outperforms 84.62% of its industry peers.
JEN's Return On Equity of 8.97% is fine compared to the rest of the industry. JEN outperforms 78.85% of its industry peers.
JEN's Return On Invested Capital of 7.16% is fine compared to the rest of the industry. JEN outperforms 78.85% of its industry peers.
The Average Return On Invested Capital over the past 3 years for JEN is in line with the industry average of 7.41%.
The 3 year average ROIC (7.15%) for JEN is below the current ROIC(7.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.14%
ROE 8.97%
ROIC 7.16%
ROA(3y)4.32%
ROA(5y)4.15%
ROE(3y)8.12%
ROE(5y)8.24%
ROIC(3y)7.15%
ROIC(5y)6.58%
JEN.DE Yearly ROA, ROE, ROICJEN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

Looking at the Profit Margin, with a value of 7.85%, JEN belongs to the top of the industry, outperforming 90.38% of the companies in the same industry.
In the last couple of years the Profit Margin of JEN has remained more or less at the same level.
The Operating Margin of JEN (12.46%) is better than 90.38% of its industry peers.
JEN's Operating Margin has improved in the last couple of years.
The Gross Margin of JEN (33.03%) is worse than 63.46% of its industry peers.
In the last couple of years the Gross Margin of JEN has remained more or less at the same level.
Industry RankSector Rank
OM 12.46%
PM (TTM) 7.85%
GM 33.03%
OM growth 3Y-1.94%
OM growth 5Y5.73%
PM growth 3Y-8.73%
PM growth 5Y0.97%
GM growth 3Y0.54%
GM growth 5Y0.38%
JEN.DE Yearly Profit, Operating, Gross MarginsJEN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so JEN is still creating some value.
The number of shares outstanding for JEN remains at a similar level compared to 1 year ago.
The number of shares outstanding for JEN remains at a similar level compared to 5 years ago.
Compared to 1 year ago, JEN has an improved debt to assets ratio.
JEN.DE Yearly Shares OutstandingJEN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
JEN.DE Yearly Total Debt VS Total AssetsJEN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

JEN has an Altman-Z score of 2.49. This is not the best score and indicates that JEN is in the grey zone with still only limited risk for bankruptcy at the moment.
JEN has a Altman-Z score of 2.49. This is comparable to the rest of the industry: JEN outperforms 51.92% of its industry peers.
The Debt to FCF ratio of JEN is 5.44, which is a neutral value as it means it would take JEN, 5.44 years of fcf income to pay off all of its debts.
JEN has a Debt to FCF ratio (5.44) which is in line with its industry peers.
A Debt/Equity ratio of 0.31 indicates that JEN is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.31, JEN perfoms like the industry average, outperforming 57.69% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 5.44
Altman-Z 2.49
ROIC/WACC1.26
WACC5.67%
JEN.DE Yearly LT Debt VS Equity VS FCFJEN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

JEN has a Current Ratio of 1.52. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.52, JEN perfoms like the industry average, outperforming 42.31% of the companies in the same industry.
A Quick Ratio of 0.77 indicates that JEN may have some problems paying its short term obligations.
JEN has a worse Quick ratio (0.77) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 0.77
JEN.DE Yearly Current Assets VS Current LiabilitesJEN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.53% over the past year.
Measured over the past 5 years, JEN shows a small growth in Earnings Per Share. The EPS has been growing by 6.54% on average per year.
JEN shows a small growth in Revenue. In the last year, the Revenue has grown by 1.39%.
The Revenue has been growing slightly by 5.46% on average over the past years.
EPS 1Y (TTM)13.53%
EPS 3Y4.03%
EPS 5Y6.54%
EPS Q2Q%-40.74%
Revenue 1Y (TTM)1.39%
Revenue growth 3Y14.12%
Revenue growth 5Y5.46%
Sales Q2Q%-4.9%

3.2 Future

JEN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.19% yearly.
JEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.76% yearly.
EPS Next Y5.08%
EPS Next 2Y11.72%
EPS Next 3Y10.46%
EPS Next 5Y10.19%
Revenue Next Year0.18%
Revenue Next 2Y2.88%
Revenue Next 3Y3.15%
Revenue Next 5Y3.76%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JEN.DE Yearly Revenue VS EstimatesJEN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
JEN.DE Yearly EPS VS EstimatesJEN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.70 indicates a correct valuation of JEN.
Based on the Price/Earnings ratio, JEN is valued cheaper than 82.69% of the companies in the same industry.
JEN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.04.
With a Price/Forward Earnings ratio of 9.48, the valuation of JEN can be described as very reasonable.
Based on the Price/Forward Earnings ratio, JEN is valued a bit cheaper than 76.92% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.64, JEN is valued rather cheaply.
Industry RankSector Rank
PE 12.7
Fwd PE 9.48
JEN.DE Price Earnings VS Forward Price EarningsJEN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JEN is valued a bit cheaper than 67.31% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JEN indicates a somewhat cheap valuation: JEN is cheaper than 63.46% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.77
EV/EBITDA 6.86
JEN.DE Per share dataJEN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
JEN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.5
PEG (5Y)1.94
EPS Next 2Y11.72%
EPS Next 3Y10.46%

4

5. Dividend

5.1 Amount

JEN has a Yearly Dividend Yield of 1.99%.
Compared to an average industry Dividend Yield of 2.87, JEN pays a bit more dividend than its industry peers.
JEN's Dividend Yield is comparable with the S&P500 average which is at 2.31.
Industry RankSector Rank
Dividend Yield 1.99%

5.2 History

Dividend Growth(5Y)0%
Div Incr Years0
Div Non Decr Years0
JEN.DE Yearly Dividends per shareJEN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2025 0.1 0.2 0.3

5.3 Sustainability

23.13% of the earnings are spent on dividend by JEN. This is a low number and sustainable payout ratio.
DP23.13%
EPS Next 2Y11.72%
EPS Next 3Y10.46%
JEN.DE Yearly Income VS Free CF VS DividendJEN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
JEN.DE Dividend Payout.JEN.DE Dividend Payout, showing the Payout Ratio.JEN.DE Dividend Payout.PayoutRetained Earnings

JENOPTIK AG

FRA:JEN (7/25/2025, 7:00:00 PM)

19.17

+0.03 (+0.16%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-13 2025-08-13
Inst Owners40.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.10B
Analysts82.35
Price Target26.02 (35.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.99%
Yearly Dividend0.35
Dividend Growth(5Y)0%
DP23.13%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.18%
Min EPS beat(2)-20.99%
Max EPS beat(2)4.63%
EPS beat(4)2
Avg EPS beat(4)-1.45%
Min EPS beat(4)-20.99%
Max EPS beat(4)13.86%
EPS beat(8)3
Avg EPS beat(8)-7.97%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.63%
Min Revenue beat(2)-3.34%
Max Revenue beat(2)-1.93%
Revenue beat(4)1
Avg Revenue beat(4)-1.42%
Min Revenue beat(4)-3.34%
Max Revenue beat(4)2.62%
Revenue beat(8)2
Avg Revenue beat(8)-5.53%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.38%
PT rev (3m)-12.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.57%
Valuation
Industry RankSector Rank
PE 12.7
Fwd PE 9.48
P/S 0.99
P/FCF 13.77
P/OCF 6.1
P/B 1.14
P/tB 3.88
EV/EBITDA 6.86
EPS(TTM)1.51
EY7.88%
EPS(NY)2.02
Fwd EY10.55%
FCF(TTM)1.39
FCFY7.26%
OCF(TTM)3.14
OCFY16.4%
SpS19.27
BVpS16.86
TBVpS4.94
PEG (NY)2.5
PEG (5Y)1.94
Profitability
Industry RankSector Rank
ROA 5.14%
ROE 8.97%
ROCE 10.43%
ROIC 7.16%
ROICexc 7.5%
ROICexgc 16.37%
OM 12.46%
PM (TTM) 7.85%
GM 33.03%
FCFM 7.22%
ROA(3y)4.32%
ROA(5y)4.15%
ROE(3y)8.12%
ROE(5y)8.24%
ROIC(3y)7.15%
ROIC(5y)6.58%
ROICexc(3y)7.54%
ROICexc(5y)6.96%
ROICexgc(3y)16.1%
ROICexgc(5y)15.71%
ROCE(3y)10.41%
ROCE(5y)9.58%
ROICexcg growth 3Y-2.02%
ROICexcg growth 5Y2.07%
ROICexc growth 3Y7.18%
ROICexc growth 5Y-3.9%
OM growth 3Y-1.94%
OM growth 5Y5.73%
PM growth 3Y-8.73%
PM growth 5Y0.97%
GM growth 3Y0.54%
GM growth 5Y0.38%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 5.44
Debt/EBITDA 1.42
Cap/Depr 132.32%
Cap/Sales 9.09%
Interest Coverage 8.57
Cash Conversion 84.38%
Profit Quality 91.98%
Current Ratio 1.52
Quick Ratio 0.77
Altman-Z 2.49
F-Score5
WACC5.67%
ROIC/WACC1.26
Cap/Depr(3y)121.37%
Cap/Depr(5y)106.88%
Cap/Sales(3y)8.22%
Cap/Sales(5y)7.57%
Profit Quality(3y)101.44%
Profit Quality(5y)95.78%
High Growth Momentum
Growth
EPS 1Y (TTM)13.53%
EPS 3Y4.03%
EPS 5Y6.54%
EPS Q2Q%-40.74%
EPS Next Y5.08%
EPS Next 2Y11.72%
EPS Next 3Y10.46%
EPS Next 5Y10.19%
Revenue 1Y (TTM)1.39%
Revenue growth 3Y14.12%
Revenue growth 5Y5.46%
Sales Q2Q%-4.9%
Revenue Next Year0.18%
Revenue Next 2Y2.88%
Revenue Next 3Y3.15%
Revenue Next 5Y3.76%
EBIT growth 1Y3.83%
EBIT growth 3Y11.91%
EBIT growth 5Y11.51%
EBIT Next Year46.8%
EBIT Next 3Y21.91%
EBIT Next 5Y14.54%
FCF growth 1Y-8.38%
FCF growth 3Y12.68%
FCF growth 5Y2.87%
OCF growth 1Y6.31%
OCF growth 3Y19.51%
OCF growth 5Y8.88%